Article ID Journal Published Year Pages File Type
7524958 Le Pharmacien Hospitalier et Clinicien 2018 6 Pages PDF
Abstract
For ICD implantation to remain financially feasible, the proportion of high-cost ICDs (subcutaneous and triple-chamber) should not exceed 50 % in order not to increase the cost of the procedure per patient in comparison to 2011. The DRG-based budget system thus penalizes centers fitting more of the more expensive devices, and fails to take account of the long-term cost savings associated with subcutaneous ICDs, which would be interesting to assess.
Related Topics
Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Pharmacology, Toxicology and Pharmaceutics (General)
Authors
, , , , ,